Search: 
You do not have permission to access this chart.
Please Sign Up or Login
News for Recro Pharma, Inc. (REPH)
Newly released Crypto mining rig for Recro Pharma, Inc. coins
minutes ago | Banggood.com
Everything Crypto on sale now!
58 minutes ago | Aliexpress.com
Recro Announces Acquisition of San Diego-based IRISYS, Creating Bi-Coastal, Full Service CDMO
2 days ago | GlobeNewsWire
Recro Announces Entry Into Letter of Intent for Acquisition of a Full Service CDMO
5 days ago | GlobeNewsWire
Recro Pharma: Q2 Earnings Insights
5 days ago | Benzinga
Recro Reports Second Quarter 2021 Financial Results
5 days ago | GlobeNewsWire
Recro To Report Financial Results for Second Quarter 2021 on August 9, 2021
a week ago | GlobeNewsWire
Recro Enters Development and Manufacturing Agreement With New Client
a month ago | GlobeNewsWire
All You Need to Know About Recro Pharma (REPH) Rating Upgrade to Buy
a month ago | Zacks Investment Research
Recro Appoints Laura L. Parks, Ph.D.
2 months ago | GlobeNewsWire
Recro Expands Capabilities for Growing Clinical Trial Services (CTS) Offerings
2 months ago | GlobeNewsWire
Recro Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
3 months ago | GlobeNewsWire

About:

Recro Pharma, Inc., a contract development and manufacturing organization, engages in the development, manufacturing, and packaging of oral solid dose drug products in the United States and internationally. The company was formerly known as Recro Pharma I, Inc. and changed its name to Recro Pharma, Inc. in August 2008. Recro Pharma, Inc. was incorporated in 2007 and is based in Malvern, Pennsylvania.

Sector:

Healthcare

Industry:

Drug Manufacturers—Specialty & Generic

Employees:

185

Address:

Recro Pharma, Inc. 490 Lapp Road Malvern PA 19355 United States

Website:

http://www.recrogainesville.com

Phone:

484-395-2470

Leave a comment

Your email address will not be published. Required fields are marked *